Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.48 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14519376 | 1.00 | SIGMAR1 (0.48) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| SCHEMBL3819958 | 1.00 | SIGMAR1 (0.48) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| SCHEMBL14519375 | 1.00 | SIGMAR1 (0.48) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| SCHEMBL4713746 | 1.00 | SIGMAR1 (0.48) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| Fluoride SCHEMBL11231130 | 0.97 | SIGMAR1 (0.46) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| Hydrochloric Acid SCHEMBL2869749 | 0.97 | SIGMAR1 (0.46) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| Water SCHEMBL29083027 | 0.97 | SIGMAR1 (0.46) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| Ammonia Solution, Strong SCHEMBL16338366 | 0.97 | SIGMAR1 (0.46) | SIGMAR1ADRA1BALOX5CYP1A2DAO | |
| SCHEMBL895491 | 0.97 | — | — | |
| SCHEMBL2076710 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118931458-B | Electronic packaging adhesive and preparation method thereof | 山东凯恩新材料科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-118931458-A | Electronic packaging adhesive and preparation method thereof | 山东凯恩新材料科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-109385176-A | A kind of bi-component fluosilicic modified epoxy joint trimming agent and preparation method thereof | 嘉力丰科技股份有限公司 | 2019-02-26 | — | — | CN | claimed |
| CN-104292111-A | Preparation method for reducing N,N-dimethyl cyclohexylformamide | WANG XIAOWEI | 2015-01-21 | — | — | CN | claimed |
| US-20080098892-A1 | Contacting with aqueous absorption medium containing tertiary aliphatic amine and activator having primary and secondary aliphatic amine functionality | BASF AKTIENGESELLSCHAFT PATENTS, TRADEMARKS AND LICENSES (DE) | 2008-05-01 | — | — | US | claimed |
| EP-1725321-A1 | METHOD FOR THE REMOVAL OF CARBON DIOXIDE FROM FLUE GASES | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-29 | — | — | EP | claimed |
| US-7026510-B2 | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | Dompé S.p.A. (IT) | 2006-04-11 | — | — | US | claimed |
| WO-2005087350-A1 | METHOD FOR THE REMOVAL OF CARBON DIOXIDE FROM FLUE GASES | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-22 | — | — | WO | claimed |
| US-20040266870-A1 | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | DOMPÉ FARMACEUTICI S.P.A. (IT) | 2004-12-30 | — | — | US | claimed |
| EP-1430020-A1 | QUATERNARY AMMONIUM SALTS OF OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dompé S.P.A. (IT) | 2004-06-23 | — | — | EP | claimed |
| WO-2003029187-A1 | QUATERNARY AMMONIUM SALTS OF OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DOMPE S.P.A. (IT) | 2003-04-10 | — | — | WO | claimed |
| EP-0923733-A1 | METHOD FOR ANALYSING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION (ADME) AND PHARMACOKINETICS PROPERTIES OF COMPOUND MIXTURES | CHIRON CORPORATION (US) | 1999-06-23 | — | — | EP | claimed |
| WO-1998009166-A1 | METHOD FOR ANALYSING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION (ADME) AND PHARMACOKINETICS PROPERTIES OF COMPOUND MIXTURES | CHIRON CORPORATION (US) | 1998-03-05 | — | — | WO | claimed |
| CN-122028918-A | TRIM7 inhibitors and uses thereof | 沙塔克实验室有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260098031-A1 | MONOCYCLIC COMPOUND HAVING GLP-1 RECEPTOR AGONIST ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2026-04-09 | — | — | US | disclosed |
| US-12378348-B2 | Method for the production of a thermoplastic polyoxazolidinone | COVESTRO DEUTSCHLAND AG (DE) | 2025-08-05 | — | — | US | disclosed |
| US-4318999-A | Low fire hazard rigid urethane insulation foam, polyol mixtures used in the manufacture thereof, and method for manufacture thereof | THE QUAKER OATS COMPANY (US) | 1982-03-09 | — | — | US | disclosed |
| US-4195149-A | Hard, rigid, non-elastomeric polyurethane, compositions | BASF AKTIENGESELLSCHAFT (DE) | 1980-03-25 | — | — | US | disclosed |
| US-4020059-A | Process for preparing tertiary amines | NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JA) | 1977-04-26 | — | — | US | disclosed |
| US-3947458-A | RHODIUM CATALYST, REACTING NITROGEN COMPOUND, OLEFIN, CARBON MONOXIDE, WATER | MONSANTO COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040266870-A1 | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | C3AR1, IL5, AP1G1 | SIGMAR1 1592/4885ADRA1B 761/4885ALOX5 35/4885 |
| US-20260098031-A1 | MONOCYCLIC COMPOUND HAVING GLP-1 RECEPTOR AGONIST ACTIVITY | GLP1R, GCGR, CCKAR | SIGMAR1 104/4885ADRA1B 169/4885ALOX5 3205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.